| 商品名 | 申请号 | 产品号 | 申请类型 | 活性成分 | 剂型/给药途径 | 规格/剂量 | RLD | RS | 申请号原始批准/暂定批准日期 | 产品号批准日期 | 申请人 | 市场状态 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| LIDOCAINE HYDROCHLORIDE | 217693 | 001 | ANDA | LIDOCAINE HYDROCHLORIDE | INJECTABLE;INJECTION | 1% | No | No | 2023/07/11 | 2023/07/11 | MANKIND PHARMA | Prescription |
| LIDOCAINE HYDROCHLORIDE | 217693 | 002 | ANDA | LIDOCAINE HYDROCHLORIDE | INJECTABLE;INJECTION | 2% | No | No | 2023/07/11 | 2023/07/11 | MANKIND PHARMA | Prescription |
| LIDOCAINE HYDROCHLORIDE | 218182 | 001 | ANDA | LIDOCAINE HYDROCHLORIDE | SOLUTION;TOPICAL | 4% | No | No | 2023/12/07 | 2023/12/07 | TARO | Prescription |
| LIDOCAINE HYDROCHLORIDE VISCOUS | 218138 | 001 | ANDA | LIDOCAINE HYDROCHLORIDE | SOLUTION;ORAL | 2% | No | No | 2024/02/20 | 2024/02/20 | PAI HOLDINGS PHARM | Prescription |
| LIDOCAINE HYDROCHLORIDE | 218411 | 001 | ANDA | LIDOCAINE HYDROCHLORIDE | SOLUTION;TOPICAL | 4% | No | No | 2024/04/29 | 2024/04/29 | THE J MOLNER | Prescription |